Stay updated on T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial
Sign up to get notified when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.

Latest updates to the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page
- Check2 days agoChange DetectedThe footer “Revision” label was updated from v3.5.2 to v3.5.3, reflecting a minor site/version change without altering the clinical study details.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded Revision v3.5.2; Removed Revision v3.5.0.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedReplaced the location name Padua with Padova for the Italy site (Padova, 35128) to reflect the official local naming.SummaryDifference0.0%

- Check38 days agoChange DetectedNaples, Italy (80131) was added as a study site and Napoli, Italy (80131) was removed, with the city name updated to Naples and the revision upgraded from 3.4.3 to 3.5.0.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision history updated to v3.4.3 with new dates (2026-03-04, 2026-02-12, 2026-02). Previous revision v3.4.2 is superseded.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded: Revision: v3.4.2; Deleted: Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.